Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
6
×
boston blog main
boston top stories
life sciences
national blog main
national top stories
sanofi
6
×
clinical trials
new york blog main
new york top stories
san francisco blog main
san francisco top stories
biotech
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
inclisiran
indiana blog main
indiana top stories
national
novartis
pcsk9
raleigh-durham blog main
raleigh-durham top stories
regeneron pharmaceuticals
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alirocumab
alnylam pharmaceuticals
cancer
cholesterol
evolocumab
What
drug
cholesterol
medicines
lowering
medco
new
wave
aces
acquire
agreed
alzheimer’s
american
announced
annual
ash
big
billion
bio
blood
borne
brings
cancer
cancers
cash
ceo
company
compound
conference
congress
deal
democrats
despite
diego
divided
drugs
elections
expensive
faces
fallout
family
Language
unset
Current search:
sanofi
×
amgen
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel